NRG1 and hydrops fetalis: The molecular mechanisms by which NRG-1 therapy attenuates the progression of HF include preventing myocardial fibrosis and apoptosis (18), reducing oxidant-producing enzymes (19), and improving myocardial contractility and diastolic capacity (20, 21).